Medical Innovation Exchange

REGiMMUNE touts 'compelling' midstage data in stem call transplant patients, readies phase 3

https://www.fiercebiotech.com/biotech/regimmune-touts-compelling-phase-2-data-stem-call-transplant-patients-readies-phase-3

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!